Paroxysmal atrial fibrillation (PAF) is common, often silent, and can be difficult to detect. Echocardiographic parameters assessing left atrial (LA) remodelling correlated with atrial fibrosis in permanent AF, but less is known about earlier stages such as PAF. We aimed to evaluate whether 2D and 3D echocardiographic (2DE and 3DE) assessment of LA anatomy and function is able to identify patients with PAF.
Introduction
Paroxysmal atrial fibrillation (PAF) is highly prevalent and often asymptomatic. 1 Long-term electrocardiographic (ECG) monitoring is the reference method to assess silent PAF for prompt antithrombotic prevention. 2 However, routine use of long-term ECG monitoring is not possible for economic reason and selecting patients who are likely to have PAF is challenging as there is currently no risk stratification score to identify them. 3 Atrial fibrillation (AF) pathophysiology is complex. Based on the Coumel concept, it requires three different disorders: (i) a trigger such as atrial ectopy from the pulmonary veins; (ii) the influence of autonomic nervous system that is modulating the probability of AF's onset; and (iii) a physical substrate that consists of atrial fibrosis/remodelling. 4 The anatomical remodelling is defined by an increase in left atrial (LA) volumes. The functional remodelling is defined by the decrease of LA functions. Three different types of atrial function have been described 5 ( Figure 1 ): (i) the reservoir function that starts when the mitral valve closes and finishes when it opens; (ii) the conduit function that starts when the mitral valve opens and ends just before the atrial contraction; and (iii) the pump function, which represents the atrial contraction.
Atrial remodelling progresses along with the evolution of AF stages. However, it is still debatable whether LA remodelling caused by PAF can be detected by echocardiography. 6 -10 Recent developments in echocardiography with three-dimensional echocardiography (3DE) offer the advantage to better assess LA structure than with 2D echocardiography (2DE) when compared with magnetic resonance imaging. 11, 12 LA functions can be assessed by volume methods (expansion index, ejection fraction, etc.) and speckle-tracking echocardiography. 5 LA 2D longitudinal strain has been described to be associated with the amount of fibrosis within the LA wall. 13, 14 More recently, 3DE allowed more complex assessment of myocardial deformation of the LA than 2DE with the ability to measure area strain (A-1). Using these advanced tools, echocardiography seems to have the potential to detect subtle LA remodelling associated with PAF. Therefore, this study aimed to evaluate whether 2DE and 3DE assessment of LA anatomy and function is able to identify patients with PAF.
Methods

Study population
Patients over 18 years of age free from any overt heart disease (valvular, coronary artery disease, pulmonary hypertension, cardiac surgery, and previous ablation procedure) were prospectively selected from the echocardiography laboratory of the Louis Pradel Hospital in Bron, France. Inclusion criteria included sinus rhythm at the time of examination and left ventricular ejection fraction (LVEF) over 50%. Medical history and 12-lead ECG were collected and interpreted retrospectively by an experienced cardiologist (M.S.). Patients with no previous history of AF, and without any cardiac symptoms including palpitation, were included in the non-PAF group. Patients with at least one episode of documented AF over 30 s duration, either on 12-lead ECG or during Holter monitoring, were included in the PAF group. ECG assessment included P-wave amplitude, QRS duration, QT interval, and Sokolow index. Local Ethics Committee approved the study under the agreement number IRB 11263. All patients provided written consent.
Echocardiography
All echocardiographic studies were performed on Artida 4D (Toshiba Medical Systems) ultrasound system with a PST-30BT transducer for 2D measurements and a PST-25SX transducer for 3D measurements.
Transthoracic echocardiography and Doppler tissue imaging
Cardiac chamber size, LVEF, LV mass, and LA dimensions were evaluated according to the recommendations of the European Society of Echocardiography. 15 LV mass was indexed to body surface area (LVMi).
Pulsed-wave Doppler at the tip of mitral valve leaflets was used to measure early (E) and late (A) diastolic filling velocities, E/A ratio, E deceleration time, and A duration. Peak early and late diastolic mitral annular velocities were measured, and then the average values of septal and lateral velocities were used as Ea and Aa, respectively. E/Ea was calculated. Atrial reverse pulmonary flow duration (Ar) was measured in a pulmonary vein. E/Ea and Am-Ar were used to evaluate LV filling pressure.
LA size and function
2D and 3D full volume acquisitions of the LA were obtained from the apical view during a short breath-hold. 2D LA images were acquired from apical four-and two-chamber views. For 3D acquisition, three small wedge-shaped subvolumes from three consecutive cardiac cycles were required to acquire a full-volume data set, resulting in a volume rate of .20 volumes/s. In 2D, LA area was assessed on the four-chamber view in end systole, and volumes were measured using the biplane modified Simpson's method.
Analysis of 3D images was based on semi-automated tracing of the LA endocardial border for the calculation of LA volumes. The endocardium has been defined on two orthogonal planes of the LA. Edges of mitral annulus were the limits of the LA endocardium. From these reference sections, the software detected the LA endocardium using a semiautomated contour-tracing algorithm. Manual modifications were made to correct automatic tracing on three cross-sections short-axis plane. LA appendage and pulmonary veins were excluded.
LA volumes were indexed to the body surface area. Maximal LA volume (MaxLAVi) was measured at the ventricular end-systolic frame just before the mitral valve opening from the apical views. Pre-atrial contraction volume (PaLAVi) was obtained from the last frame before atrial contraction. Minimal atrial volume (MinLAVi) was measured at the end of LV diastole, just before the closure of the mitral valve.
Different atrial function parameters were calculated with the following formulas ( Figure 1 Area and longitudinal strain were studied from 3D full volume acquisitions. We measured: † peak and pre-atrial contraction values of LA longitudinal strain (L-1-Max and L-1-PA, respectively). These two parameters explore the reservoir and pump functions, respectively; † peak and pre-atrial contraction values of LA area strain (A-1-Max and A-1-PA, respectively). These two parameters explore the reservoir and pump functions, respectively.
Statistical analysis
Results were expressed as mean + SD or median and interquartile range, depending on the normal distribution as assessed by the Shapiro -Wilk test. Comparisons between PAF and non-PAF groups were performed using unpaired t-test for continuous variables and x 2 test for categorical variables, as appropriate.
Receiver operating characteristic (ROC) curves were constructed to determine the optimal sensitivity and specificity of each parameter. The area under the curve (AUC) was calculated to assess the overall performance of various variables for the detection of PAF. For each tested variable, the best threshold was estimated, according to the Youden index. bootstrapped, and 2000 replicates were sampled weighting cases and controls. For each parameter, the sensitivity and specificity of the best threshold identified on our sample were estimated on each replicate. The 2.5-97.5 percentiles of the bootstrap distribution were returned. To investigate independent associations between atrial echocardiographic variable and PAF, a logistic regression for each echocardiographic parameter was performed. Each regression was adjusted for age, negative inotropic drugs, and indexed LV mass. Adjusted odds ratios were estimated for each atrial echocardiographic variable found significantly associated with PAF. Tests with P-values less than 0.05 were considered to be statistically significant.
Intra-and inter-observer variability was assessed in 15 random patients and is reported in Supplementary data online.
Statistical tests were performed with SPSS version 20 (SPSS Inc.) and R (software 3.0.2, 2013).
Results
Clinical and ECG characteristics
One hundred and two patients were included in our study from March to December 2014. Forty-four patients had PAF. Non-PAF patients were younger than PAF patients. Both groups had the same number of cardiovascular risk factors ( Table 1) . Considering treatment, anti-arrhythmics, negative inotropes (beta-blockers, verapamil, or diltiazem), and anticoagulants were more prevalent among PAF patients. P-wave duration and amplitude were similar between groups, respectively (92.2 vs. 82.9 ms, P ¼ 0.18 and 0.17 vs. 0.18 mV, P ¼ 0.825). PR duration was not different in the two groups (173 vs. 162 ms, P ¼ 0.24). In both groups, there was no LV hypertrophy by ECG criteria, as measured by the Sokolow index (18 vs. 16 mV; P ¼ 0.26). Heart rate during echocardiography was similar between PAF and non-PAF patients (64 vs. 69/min, P ¼ 0.18) and so were QRS duration and QT interval (86.7 vs. 78.9 ms, P ¼ 0.24 and 416 vs. 409 ms, P ¼ 0.38, respectively).
Echocardiographic characteristics
Echocardiographic characteristics according to patient's group Ventricular parameters There was no significant difference in LV end-diastolic diameter, LV end-systolic diameter, and LVEF between the two groups ( Table 2 ). Diastolic LV filling pressure assessed by the E/E ′ ratio and pulmonary venous flow as described in the European recommendation were similar in the two groups. LVMi was higher in the PAF group.
Echocardiographic atrial remodelling
Atrial volumes were greater in the PAF group compared with the non-PAF group in both 2D and 3D modes ( Table 3 and Figures 2  and 3) . Using 3DE, all LA functions were significantly impaired in the PAF group compared with the non-PAF group, regardless of the method of measurement (volume or strain method). Using 2DE, only the reservoir and pump functions were impaired in the PAF group. The reservoir function, assessed by 2D-p-LAEF, was not significantly impaired compared with the non-PAF group.
Evaluation of echocardiographic parameters in the detection of PAF Results obtained from the ROC curves are displayed in Table 4 and Figure 4 . The sensitivity and specificity values for the detection of PAF determined on the bootstrapped populations are reported in Table 5 .
Multivariate analysis on the relationship of echocardiographic parameters and PAF Age and LA echocardiographic parameters remained significantly associated with PAF after adjustment for age, negative inotropic drugs, and indexed LV mass. Adjusted odd ratios for 3DE parameters with the highest AUC were 1.08 (1.03 -1.14) for 3D-MinLAVi, 1.04 (1.01 -1.08) for 3D-MaxLAVi, 0.88 (0.82 -0.95) for 3D-LAEF, and 0.93 (0.89 -0.98) for A-1-Max (all P-values less than 0.05).
Discussion
The main findings of our study are as follows: (i) anatomical and functional LA remodelling is independently and strongly associated with PAF, suggesting that these parameters are valuable for the detection of PAF and (ii) all parameters are accurate, but minimal LA Figure 3 Main 3DE parameters of the LA remodelling. LA volumes are increased and reservoir function is impaired in the PAF group compared with the non-PAF group. LA, left atrial; PAF, paroxysmal atrial fibrillation. indexed volume and 3DE assessment of LA function seem to have higher discriminating power.
PAF is associated with anatomical and functional remodelling
Persistent and permanent AF is associated with LA dilatation, 5, 16, 17 but this relationship is less evident in PAF. 9, 10 In our study, we have shown that even at the stage of PAF, LA anatomical and functional remodelling is present and detectable by 2DE and 3DE. Minimal volume obtained on 2DE or 3DE seems to be the most accurate parameter reflecting anatomical remodelling associated with PAF. Fatema et al. 18 had similar results with 2D minimal volume, which was a major predictor of the onset of PAF. Additionally, minimal LA volume is generally considered to be associated with cardiovascular adverse events. 5, 19 Regarding LA dysfunction, in our study, using 2DE, reservoir and pump functions were impaired in the PAF group. These results are consistent with Toh et al., 20 who reported that in patients with high blood pressure, PAF was associated with an altered contractile pump function. Using 3DE, we found that all atrial functions were impaired in the PAF group. However, impairment of reservoir function assessed by 3D-LAEF and 3D area strain was the most accurate marker of PAF. Our finding is consistent with Pagola et al., 21 who pointed out that longitudinal 2D strain peak was a predictor of PAF in patients with cryptogenic stroke. Our results are reinforced by the fact that previous publications reported strong correlations between the amount of fibrosis and strain parameters.
13,14
From physiology to echocardiography
Fibrosis is the main substrate of AF 4, 22, 23 by creating conduction heterogeneity in the atrial tissue. 24 In contrast, it is highly possible that AF itself generates fibrosis. 25 Using CMR with late gadolinium enhancement sequences, recent clinical studies reported that patients with persistent AF had more LA remodelling and fibrosis than those with PAF 7 and that the extent of LA fibrosis correlates with LA dysfunction. 7, 14 Using 2DE, alteration of LA strain parameters has been
shown to be associated with the amount of fibrosis within LA tissue in patients undergoing mitral valve surgery. 13 Our results showed that LA remodelling associated with AF is detectable by 2DE and 3DE even at the stage of PAF. This remodelling probably reflects an early LA fibrosis.
Role of 3D echocardiography in LA evaluation
In the past few years, technological improvements made 3DE with 3D strain widely available. LA 3DE volume measurement has been favourably correlated with CMR 11 or CCT values, 26 compared with 2DE. Mochizuki et al. 27 recently showed that 3D strain was feasible and reproducible. To our knowledge, our study is the first to compare 3D strain parameters with commonly used measures such as 2D volumes and 2D functional assessment of the LA. In our study, we showed that parameters derived from 3D volume tend to be stronger predictors of PAF with higher AUC than those obtained with 2D volume. The first explanation is that assessments of three-dimensional volumes are not based on assumption such as 2D technique. As the expansion of the LA is asymmetric, anatomical extrapolations generate significant measurement error. Secondly with the advent of 3D acquisitions, speckles in the myocardium can be tracked in 3D space, which has a theoretical advantage to overcome out-of-plane motion 28 and could explain better accuracy for 3D parameters. However, the accuracy of 2D parameters was acceptable in our study with a sensitivity of 79% and a specificity of 86% for 2D-Min-LAVi for the detection of PAF patients. Therefore, 2D echo can provide useful information for identification of patients with PAF when 3D is not available.
Study limitations
Our case-control study included patients from the cardiology outpatient clinic. This explains that 'non-PAF patients' had risk factors and that we have chosen to label this group 'non-PAF patients' rather than 'controls'. Because of this recruitment, the PAF group was older and had a greater LV mass than the non-PAF group. It is known that with ageing LA volumes and pump function increase, whereas conduit function decreases. 29, 30 Nevertheless, our multivariate analysis which included age and myocardial mass as potential confounding factors has confirmed echocardiographic parameters to be independently associated with PAF. Non-PAF patients were those in sinus rhythms and without any history of AF or symptom. It is well known that long-term ECG monitoring is the gold standard method for the diagnosis of PAF.
Therefore, we cannot completely exclude the occurrence of PAF in some of our patients included in the 'non-PAF' group.
Finally, our cut-off values need to be further tested in other series.
Study perspectives
As mentioned earlier, the fact that AF is associated with anatomical remodelling is widely admitted. 5, 8, 16 However, LA anatomical and functional assessment is not recommended in the guidelines, neither for the screening of PAF nor for the management of patients with PAF. 3 As suggested by our results, 2DE and 3DE assessment of LA volumes and strain might be useful to identify patients with silent PAF. Future prospective cohort studies, ideally using long-term ECG monitoring as gold standard, are needed to confirm these results and determine precise cut-off values able to identify patients at high risk of PAF.
Conclusion
Anatomical and functional LA remodelling assessed by 2DE and 3DE is independently and strongly associated with PAF, suggesting that these parameters are valuable for the detection of PAF.
Supplementary data
Supplementary data are available at European Heart JournalCardiovascular Imaging online.
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